News & Updates

Treatment with sotrovimab does not appear to confer protection against severe forms of COVID-19 in a setting dominated by the Omicron BA.2 subvariant, a study has found.

Many infectious disease-related hospital admissions in patients with inflammatory bowel disease may have been prevented by immunization, suggests a study.

Patients with COVID-19 show very low levels of 25-hydroxyvitamin D and zinc, regardless of age, sex, and comorbidities, reports a study. Vitamin D and zinc deficiency appears to be relevant factors in identifying individuals who are susceptible to SARS-CoV-2 infection.

Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.

In the phase III SPRINTER trial, inhaled interferon-beta-1a (IFN-β1a) showed encouraging signals for preventing disease progression or death in hospitalized COVID-19 patients.

Keeping COVID-19 patients in the prone position even while they are awake appears to reduce the need for invasive mechanical ventilation (IMV), according to a recent Singapore study.

Men with Trichomoniasis vaginalis infections appear to be at an elevated risk of prostate cancer (PCa) and benign prostate hyperplasia (BPH), according to a recent study.

Despite being vaccinated against COVID-19, women with gout have an excess risk of developing SARS-CoV-2 infection as well as severe sequelae from it, according to a study.

Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.